BlossomHill Therapeutics
BlossomHill Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 2 tracked investors.
About BlossomHill Therapeutics
BlossomHill Therapeutics is a company founded in 2018 headquartered in Israel. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
BlossomHill Therapeutics is a clinical-stage biotechnology company that designs and develops small-molecule oncology medicines aimed at overcoming treatment resistance and improving selectivity, durability, and safety. Their work focuses on precision cancer therapies and rational drug design to address hard-to-treat tumors.
Explore BlossomHill Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.